Skip to main content

Want a detailed portfolio tracker?

Phio Pharmaceuticals (PHIO) P/E (2020 - 2026)

Phio Pharmaceuticals (PHIO) P/E from Mar 31, 2020 to Jul 21, 2026. The TTM Phio Pharmaceuticals (PHIO) P/E is -0.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Phio Pharmaceuticals (PHIO)

YearP/EChange
2026-0.80+9.61%
2025-0.73-49.23%
2024-1.44+37.95%
2023-1.04-79.12%
2022-4.99-73.84%
2021-19.05-75.06%
2020-76.40N/A

Comparison Phio Pharmaceuticals (PHIO) P/E with competitors

Phio Pharmaceuticals (PHIO) P/E is -0.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.21%
NBYStablecoin Development Corp0.00-100.54%
ENLVEnlivex Ltd0.07-109.36%
FGENFibroGen Inc0.24-130.03%
CHRSCoherus Biosciences Inc0.85-206.16%
FBIOFortress Biotech Inc0.95-218.73%
ORMPOramed Pharmaceuticals Inc1.50-288.04%
AGENAgenus Inc3.01-476.52%
INVAInnoviva Inc3.15-494.58%
VXRTVaxart Inc3.55-544.09%
CRMDCorMedix Inc3.63-553.93%
CVACCureVac N.V.4.45-656.17%
GLPGGalapagos NV4.86-707.87%
SRPTSarepta Therapeutics Inc4.88-710.77%
ABEOAbeona Therapeutics Inc5.39-774.00%
ABUSArbutus Biopharma Corp5.60-800.04%
ZVRAZevra Therapeutics Inc5.89-836.52%
SPROSpero Therapeutics Inc6.23-879.20%
CGENCompugen Ltd6.31-889.90%
RIGLRigel Pharmaceuticals6.87-959.73%
SLXNSilexion Therapeutics Corp7.30-1012.77%
OMEROmeros Corporation9.26-1258.31%
AUPHAurinia Pharmaceuticals Inc9.58-1299.12%
PLXProtalix BioTherapeutics Inc10.89-1462.51%
ACADAcadia Pharmaceuticals Inc11.73-1567.29%
TBPHTheravance Biopharma Inc12.26-1634.05%
ADMAAdma Biologics Inc12.42-1653.57%
HRMYHarmony Biosciences Holdings Inc13.82-1828.97%
SABSSAB Biotherapeutics Inc14.14-1868.51%
NAGENiagen Bioscience Inc14.82-1953.82%
INCYIncyte Corp15.82-2079.48%
REGNRegeneron Pharmaceuticals Inc15.86-2083.74%
PBYIPuma Biotechnology Inc17.32-2266.28%
CPRXCatalyst Pharmaceuticals Inc17.44-2281.74%
EXELExelixis Inc17.54-2294.09%
TGTXTG Therapeutics Inc18.97-2472.75%
MDXGMimedx Group Inc20.55-2671.22%
XOMAXOMA Royalty Corp22.87-2961.81%
ARGXArgen X SE24.30-3139.88%
CTMXCytomX Therapeutics Inc24.82-3205.32%
XOMAOXOMA Royalty Corp25.34-3270.84%
HALOHalozyme Therapeutics Inc25.62-3305.73%
XOMAPXOMA Royalty Corp25.67-3311.54%
VRTXVertex Pharmaceuticals Inc27.99-3602.37%
RPRXRoyalty Pharma plc - Class A28.69-3689.04%
SLNOSoleno Therapeutics Inc29.02-3730.06%
ASNDAscendis Pharma A/S30.09-3863.95%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4843.10%
APLSApellis Pharmaceuticals Inc39.02-4981.87%
BMRNBiomarin Pharmaceutical Inc42.21-5381.05%
KRYSKrystal Biotech Inc45.34-5772.84%
ONCBeiGene Ltd69.54-8800.08%
TECHBio-Techne Corp101.96-12855.83%
VCELVericel Corp109.92-13852.06%
ALNYAlnylam Pharmaceuticals Inc117.96-14858.40%
GMABGenmab140.29-17651.53%
TLXTelix Pharmaceuticals Ltd162.15-20386.65%
CORTCorcept Therapeutics Inc212.86-26730.23%